Braidwell LP Viking Therapeutics, Inc. Transaction History

Braidwell LP

$1.79 Billion
Q4 2024

A detailed history of Braidwell LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Braidwell LP holds 1,479,666 shares of VKTX stock, worth $35.4 Million. This represents 3.34% of its overall portfolio holdings.

Number of Shares

1,479,666

Previous 1,156,977 27.89%

Holding current value

$35.4 Million

Previous $73.2 Billion 99.92%

% of portfolio

3.34%

Previous 2.08%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$38.28 - $78.03 $12.4 Million - $25.2 Million	322,689 Added 27.89%	1,479,666 $59.5 Million
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $2.5 Million - $3.53 Million	50,072 Added 4.52%	1,156,977 $73.2 Billion
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $18.7 Million - $31.6 Million	393,805 Added 55.22%	1,106,905 $58.7 Billion
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $12.4 Million - $67.4 Million	713,100 New	713,100 $58.5 Billion

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $1.84B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.

Account